Journal of Clinical Endocrinology & Metabolism, Vol 67, 760-767, Copyright © 1988 by Endocrine Society

ARTICLES

Glucose metabolism in obesity: influence of body fat distribution

AN Peiris, MF Struve, RA Mueller, MB Lee and AH Kissebah
Department of Medicine, Medical College of Wisconsin, Milwaukee 53226.

The dose-response relationships between portal venous insulin concentrations and hepatic glucose production and between peripheral insulin concentrations and peripheral glucose utilization were determined in 8 nonobese and 17 obese premenopausal women with either upper or lower body fat localization. The glucose production dose- response curves for the two obese groups were shifted to the right at all levels of portal insulinemia. The upper body obese women had a greater rightward shift compared to the lower body obese women. The peripheral glucose utilization dose-response curve was shifted to the right in the lower body obese women, but maximal glucose utilization was normal. The upper body obese women had both a greater rightward shift and a marked reduction in maximal glucose utilization. The insulin concentrations that had half-maximal effects on glucose production and utilization were similar in each group. These results indicate that the liver is not inherently more sensitive to insulin than peripheral tissues. Obesity is associated with a moderate diminution of hepatic and peripheral insulin sensitivity. Upper body fat localization in obese women is characterized by a greater diminution in insulin sensitivity and decline in peripheral insulin responsivity than is lower body fat localization. The marked peripheral insulin resistance in the former group may account for the increased prevalence of glucose intolerance.

This article has been cited by other articles:

				K. McAuley and J. Mann Thematic review series: Patient-Oriented Research. Nutritional determinants of insulin resistance J. Lipid Res., August 1, 2006; 47(8): 1668 - 1676. [Abstract] [Full Text] [PDF]

				A. Garg Regional Adiposity and Insulin Resistance J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4206 - 4210. [Full Text] [PDF]

				R. Basu, R. J. Singh, A. Basu, E. G. Chittilapilly, C. M. Johnson, G. Toffolo, C. Cobelli, and R. A. Rizza Splanchnic Cortisol Production Occurs in Humans: Evidence for Conversion of Cortisone to Cortisol Via the 11-{beta} Hydroxysteroid Dehydrogenase (11{beta}-HSD) Type 1 Pathway Diabetes, August 1, 2004; 53(8): 2051 - 2059. [Abstract] [Full Text] [PDF]

				B.-J. Shen, J. F. Todaro, R. Niaura, J. M. McCaffery, J. Zhang, A. Spiro III, and K. D. Ward Are Metabolic Risk Factors One Unified Syndrome? Modeling the Structure of the Metabolic Syndrome X Am. J. Epidemiol., April 15, 2003; 157(8): 701 - 711. [Abstract] [Full Text] [PDF]

				S. J. McNulty, E. Ur, and G. Williams A Randomized Trial of Sibutramine in the Management of Obese Type 2 Diabetic Patients Treated With Metformin Diabetes Care, January 1, 2003; 26(1): 125 - 131. [Abstract] [Full Text] [PDF]

				T. A. Gresl, R. J. Colman, E. B. Roecker, T. C. Havighurst, Z. Huang, D. B. Allison, R. N. Bergman, and J. W. Kemnitz Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E757 - E765. [Abstract] [Full Text] [PDF]

				N. Barzilai and I. Gabriely The Role of Fat Depletion in the Biological Benefits of Caloric Restriction J. Nutr., March 1, 2001; 131(3): 903S - 906. [Abstract] [Full Text]

				A. H. Kissebah, G. E. Sonnenberg, J. Myklebust, M. Goldstein, K. Broman, R. G. James, J. A. Marks, G. R. Krakower, H. J. Jacob, J. Weber, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome PNAS, December 19, 2000; 97(26): 14478 - 14483. [Abstract] [Full Text] [PDF]

				E. Ferrannini Insulin Resistance versus Insulin Deficiency in Non-Insulin-Dependent Diabetes Mellitus: Problems and Prospects Endocr. Rev., August 1, 1998; 19(4): 477 - 490. [Abstract] [Full Text] [PDF]